Semaglutide Offers Hope for Managing Dangerous Side-Effects of Antipsychotic Medications
New clinical evidence suggests that the diabetes and obesity medication Semaglutide may help reverse the metabolic side-effects commonly experienced by…
Home »
Schizophrenia
Semaglutide for Schizophrenia: Clinical Trial Shows Major Benefits for Metabolic Health
A new clinical trial suggests that a diabetes medication , typically used to treattype 2 diabetes , may also help…
Semaglutide Shows Promise in Tackling Metabolic Risks Among Schizophrenia Patients on Antipsychotics
A new Danish clinical trial has found that semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist, can substantially improve metabolic health…
Semaglutide Found Effective for Weight Loss in Schizophrenia Patients on Clozapine: Small Trial Results
A recent article published by Epocrates highlights the promising results of a small clinical trial examining the use of Semaglutide…
